WallStreetZenWallStreetZen

NASDAQ: CBIO
Crescent Biopharma Inc Stock Ownership - Who owns Crescent Biopharma?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Crescent Biopharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Joshua T. BrummCEO2026-09-187,837$16.71
$130.96kSell
Jonathan McNeillCOO;Pres2026-09-183,839$16.71
$64.15kSell
Richard William ScalzoCFO2026-09-16568$17.90
$10.17kSell
Jan PinkasCSci2026-09-16658$17.90
$11.78kSell
Joshua T. BrummCEO2026-09-161,610$17.90
$28.82kSell
Jonathan McNeillCOO;Pres2026-09-16731$17.90
$13.08kSell
Ryan LynchCAO;Treas;SVP2026-09-16240$17.90
$4.30kSell
Barbara Harlin BisphamCLO;Sec2026-09-16620$17.90
$11.10kSell
Ellie Eunkyung ImMed2026-09-16623$17.90
$11.15kSell
Fairmount Funds Management LLCDirector2026-07-16853,450$14.50
$12.38MBuy

1 of 2

CBIO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CBIO insiders and whales buy or sell their stock.

CBIO Shareholders

What type of owners hold Crescent Biopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Scott D. Sandell37.84%14,056,571$181.47MInsider
M. James Barrett35.49%13,182,418$170.19MInsider
Peter J. Barris35.49%13,182,418$170.19MInsider
Siren LLC23.12%8,589,064$110.88MInsider
Fairmount Funds Management LLC17.09%6,349,182$81.97MInsider
Invus Public Equities LP17.01%6,317,565$81.56MInsider
New Enterprise Associates 10 L P13.45%4,995,664$64.49MInsider
New Enterprise Associates 13 LP11.02%4,093,377$52.85MInsider
Sanofi3.21%1,193,625$15.41MInsider
Michael A. Henos2.68%995,395$12.85MInsider

1 of 3

CBIO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CBIO0.04%99.96%Net BuyingNet Selling
MDXG0.08%83.33%Net Buying
PHAT0.09%41.16%Net SellingNet Selling
CTMX0.10%10.14%Net Selling
RGNX0.06%19.73%Net SellingNet Buying
View Top Biotech Stocks

Crescent Biopharma Stock Ownership FAQ

Who owns Crescent Biopharma?

Crescent Biopharma (NASDAQ: CBIO) is owned by 0.08% institutional shareholders, 206.63% Crescent Biopharma insiders, and 0.00% retail investors. Scott D. Sandell is the largest individual Crescent Biopharma shareholder, owning 14.06M shares representing 37.84% of the company. Scott D. Sandell's Crescent Biopharma shares are currently valued at $181.47M.

If you're new to stock investing, here's how to buy Crescent Biopharma stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.